The managing director of one of Australia’s pre-eminent eye research institutions is a leading scientist behind experiments on mice that have shown promise for developing new gene therapies for both glaucoma and dementia. Read more
MIDO postponed until 2022
Organisers of Milan’s eyewear trade show MIDO have announced this year’s event will run in an online format, with the in-person edition not to take place until early 2022. Read more
Rodenstock sale going ahead with Apax acquisition
Funds advised by global private equity advisory firm Apax are set to acquire ophthalmic lens manufacturer Rodenstock Group in a deal reported to be worth AU$2.3 billion. Read more
European Commission clears EssilorLuxottica’s GrandVision takeover, 350 stores to be divested
The European competition watchdog has cleared EssilorLuxottica’s acquisition of Europe’s largest retail optical chain GrandVision, on the condition that around 350 stores are divested across three countries. Read more
SMILE performed on more than four million eyes
Four million eyes have now been treated globally with Zeiss Meditec’s SMILE procedure, helping cement the company’s dominance in the laser vision correction segment where it holds 27% market share. Read more
Long-term study shows daily disposables ‘have minimal effect’ on children’s ocular physiology
Recently published results of an extensive study into the physiological response to daily disposable soft contact lenses are adding to a growing body of evidence in support of contact lens wear in children for myopia control. Read more
Aussie researchers help identify 127 glaucoma genes in largest study of its kind
Australian researchers have been at the fore of the largest genetic study of glaucoma that has identified 44 new genetic variants that may lead to new treatment targets. Read more
Engineer behind Varilux progressive dies aged 94
The inventor of the Essilor’s pioneering Varilux progressive lens has died in Paris at the age of 94. Read more
Ophthalmology’s most life-changing procedures revealed
Seventy-five percent of ophthalmic interventions investigated in a major study have shown evidence of improving quality of life for patients with eye disease, with cataract surgery and anti-VEGF therapy singled out as some of the most important procedures. Read more
CooperVision and Essilor announce JV for acquisition of myopia spectacle lens
The parent companies of CooperVision and Essilor have announced a new joint venture to acquire a spectacle lens approved for myopia control in several countries. Read more